Literature DB >> 26789234

Flavokawains A and B from kava (Piper methysticum) activate heat shock and antioxidant responses and protect against hydrogen peroxide-induced cell death in HepG2 hepatocytes.

Keanu D Pinner1, Christina T K Wales1, Rachel A Gristock1, Hoa T Vo1, Nadine So1, Aaron T Jacobs1,2.   

Abstract

Context Flavokawains are secondary metabolites from the kava plant (Piper methysticum Forst. f., Piperaceae) that have anticancer properties and demonstrated oral efficacy in murine cancer models. However, flavokawains also have suspected roles in rare cases of kava-induced hepatotoxicity. Objective To compare the toxicity flavokawains A and B (FKA, FKB) and monitor the resulting transcriptional responses and cellular adaptation in the human hepatocyte cell line, HepG2. Materials and methods HepG2 were treated with 2-100 μM FKA or FKB for 24-48 h. Cellular viability was measured with calcein-AM and changes in signalling and gene expression were monitored by luciferase reporter assay, real-time PCR and Western blot of both total and nuclear protein extracts. To test for subsequent resistance to oxidative stress, cells were pretreated with 50 μM FKA, 10 μM FKB or 10 μM sulphoraphane (SFN) for 24 h, followed by 0.4-2.8 mM H2O2 for 48 h, and then viability was assessed. Results FKA (≤100 μM) was not toxic to HepG2, whereas FKB caused significant cell death (IC50=23.2 ± 0.8 μM). Both flavokawains activated Nrf2, increasing HMOX1 and GCLC expression and enhancing total glutathione levels over 2-fold (p < 0.05). FKA and FKB also activated HSF1, increasing HSPA1A and DNAJA4 expression. Also, flavokawain pretreatment mitigated cell death after a subsequent challenge with H2O2, with FKA being more effective than FKB, and similar to SFN. Conclusions Flavokawains promote an adaptive cellular response that protects hepatocytes against oxidative stress. We propose that FKA has potential as a chemopreventative or chemotherapeutic agent.

Entities:  

Keywords:  Cell stress; HSF1; Nrf2; hepatotoxic; viability

Mesh:

Substances:

Year:  2016        PMID: 26789234      PMCID: PMC5040346          DOI: 10.3109/13880209.2015.1107104

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  49 in total

1.  Kava hepatotoxicity with Western herbal products: does it occur with traditional kava use?

Authors:  Bart J Currie; Alan R Clough
Journal:  Med J Aust       Date:  2003-05-05       Impact factor: 7.738

Review 2.  Oxidative signaling and glutathione synthesis.

Authors:  Henry Jay Forman; Dale A Dickinson
Journal:  Biofactors       Date:  2003       Impact factor: 6.113

3.  Induction of heat shock protein 70 protects mesangial cells against oxidative injury.

Authors:  H C Chen; J Y Guh; J H Tsai; Y H Lai
Journal:  Kidney Int       Date:  1999-10       Impact factor: 10.612

Review 4.  Constituents in kava extracts potentially involved in hepatotoxicity: a review.

Authors:  Line R Olsen; Mark P Grillo; Christian Skonberg
Journal:  Chem Res Toxicol       Date:  2011-05-03       Impact factor: 3.739

Review 5.  Kava hepatotoxicity: pathogenetic aspects and prospective considerations.

Authors:  Rolf Teschke
Journal:  Liver Int       Date:  2010-10       Impact factor: 5.828

Review 6.  Systems analysis of protein modification and cellular responses induced by electrophile stress.

Authors:  Aaron T Jacobs; Lawrence J Marnett
Journal:  Acc Chem Res       Date:  2010-05-18       Impact factor: 22.384

7.  Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives.

Authors:  Florence Folmer; Romain Blasius; Franck Morceau; Jioji Tabudravu; Mario Dicato; Marcel Jaspars; Marc Diederich
Journal:  Biochem Pharmacol       Date:  2006-02-07       Impact factor: 5.858

8.  Suppression of iNOS and COX-2 expression by flavokawain A via blockade of NF-κB and AP-1 activation in RAW 264.7 macrophages.

Authors:  Dong-Joo Kwon; Sung Mi Ju; Gi Soo Youn; Soo Young Choi; Jinseu Park
Journal:  Food Chem Toxicol       Date:  2013-05-28       Impact factor: 6.023

9.  Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.

Authors:  Jerome Sarris; Con Stough; Chad A Bousman; Zahra T Wahid; Greg Murray; Rolf Teschke; Karen M Savage; Ashley Dowell; Chee Ng; Isaac Schweitzer
Journal:  J Clin Psychopharmacol       Date:  2013-10       Impact factor: 3.153

10.  The flavokawains: uprising medicinal chalcones.

Authors:  Nadiah Abu; Wan Yong Ho; Swee Keong Yeap; M Nadeem Akhtar; Mohd Puad Abdullah; Abdul Rahman Omar; Noorjahan Banu Alitheen
Journal:  Cancer Cell Int       Date:  2013-10-22       Impact factor: 5.722

View more
  9 in total

1.  Protective effect of kava constituents in an in vitro model of oral mucositis.

Authors:  Callisthenis Yiannis; Kevin Huang; An Nhien Tran; Cathy Zeng; Emily Dao; Oliver Baselyous; Muaaz Adil Mithwani; Rita Paolini; Nicola Cirillo; Tami Yap; Michael McCullough; Antonio Celentano
Journal:  J Cancer Res Clin Oncol       Date:  2020-05-20       Impact factor: 4.553

2.  Tea Polyphenols Enhanced the Antioxidant Capacity and Induced Hsps to Relieve Heat Stress Injury.

Authors:  Bin Yin; Ruirui Lian; Zhen Li; Yueyue Liu; Shifa Yang; Zhongli Huang; Zengcheng Zhao; Ying Li; Chuanxi Sun; Shuqian Lin; Renzhong Wan; Guiming Li
Journal:  Oxid Med Cell Longev       Date:  2021-08-06       Impact factor: 6.543

3.  Kavalactone yangonin induces autophagy and sensitizes bladder cancer cells to flavokawain A and docetaxel via inhibition of the mTOR pathway.

Authors:  Zhongbo Liu; U-Syn Ha; Ke Yu; Chunli Wu; Noriko Yokoyama; Xiaolin Zi
Journal:  J Biomed Res       Date:  2017-09-26

4.  Chalcone flavokawain A attenuates TGF-β1-induced fibrotic pathology via inhibition of ROS/Smad3 signaling pathways and induction of Nrf2/ARE-mediated antioxidant genes in vascular smooth muscle cells.

Authors:  You-Cheng Hseu; Ting-Yu Yang; Mei-Ling Li; Peramaiyan Rajendran; Dony Chacko Mathew; Chia-Hsuan Tsai; Ruei-Wan Lin; Chuan-Chen Lee; Hsin-Ling Yang
Journal:  J Cell Mol Med       Date:  2018-12-13       Impact factor: 5.310

5.  Anti-Apoptotic Effect of Flavokawain A on Ochratoxin-A-Induced Endothelial Cell Injury by Attenuation of Oxidative Stress via PI3K/AKT-Mediated Nrf2 Signaling Cascade.

Authors:  Peramaiyan Rajendran; Abdullah M Alzahrani; Vishnu Priya Veeraraghavan; Emad A Ahmed
Journal:  Toxins (Basel)       Date:  2021-10-21       Impact factor: 4.546

6.  Gene Expression Analysis Reveals the Concurrent Activation of Proapoptotic and Antioxidant-Defensive Mechanisms in Flavokawain B-Treated Cervical Cancer HeLa Cells.

Authors:  Swee Keong Yeap; Nadiah Abu; Nadeem Akthar; Wan Yong Ho; Huynh Ky; Sheau Wei Tan; Noorjahan Banu Alitheen; Tunku Kamarul
Journal:  Integr Cancer Ther       Date:  2016-07-24       Impact factor: 3.279

7.  Discovery of 4-Anilinoquinolinylchalcone Derivatives as Potential NRF2 Activators.

Authors:  Yu-Tse Kao; Yi-Siao Chen; Kai-Wei Tang; Jin-Ching Lee; Chih-Hua Tseng; Cherng-Chyi Tzeng; Chia-Hung Yen; Yeh-Long Chen
Journal:  Molecules       Date:  2020-07-08       Impact factor: 4.411

Review 8.  The Keap1/Nrf2-ARE Pathway as a Pharmacological Target for Chalcones.

Authors:  Matheus de Freitas Silva; Letizia Pruccoli; Fabiana Morroni; Giulia Sita; Francesca Seghetti; Claudio Viegas; Andrea Tarozzi
Journal:  Molecules       Date:  2018-07-20       Impact factor: 4.411

9.  Nutraceutical Screening in a Zebrafish Model of Muscular Dystrophy: Gingerol as a Possible Food Aid.

Authors:  Rosario Licitra; Maria Marchese; Letizia Brogi; Baldassare Fronte; Letizia Pitto; Filippo M Santorelli
Journal:  Nutrients       Date:  2021-03-19       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.